参考文献

1.詹思延.流行病学.第7版.北京：人民卫生出版社，2012.
2. Verma M.Cancer Epidemiology.Humana Press，2009.
3. Hakama M，Chamberlain J，Day NE，et al.Evaluation of screening programmes for gynaecological cancer.Br J Cancer，1985，52（4）：669-673.
4. David S，Fraumeni JF Jr.Cancer Epidemiology and Prevention.London：Oxford University Press，Inc，2006.
5. Habbema JD，van Oortmarssen GJ，van Putten DJ，et al.Age-specific reduction in breast cancer mortality by screening：an analysis of the results of the Health Insurance Plan of Greater New York study.J Natl Cancer Inst，1986，77（2）：317-320.
6. Zhu CS，Pinsky PF，Kramer BS，et al.The prostate，lung，colorectal，and ovarian cancer screening trial and its associated research resource.J Natl Cancer Inst，2013，105（22）：1684-1693.
7. Marcus PM，Bergstralh EJ，Zweig MH，et al.Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis.Natl Cancer Inst，2006，98（11）：748-756.
8. Baron JA.Screening for cancer with molecular markers：progress comes with potential problems.Nat Rev Cancer，2012，12（5）：368-371.
9. Chen YC，Hunter DJ.Molecular Epidemiology of Cancer.CA Cancer J Clin，2005，55（1）：45-54.
10. Tong YQ，Zhang ZJ，Liu B，et al.Autoantibodies as potential biomarkers for nasopharyngeal carcinoma.Proteomics，2008，8（15）：3185-3193.
11. Raychaudhuri S.Mapping rare and common causal alleles for complex human diseases.Cell，2011，147（1）：57-69.
12. Michailidou K，Hall P，Gonzalez-Neira A，et al.Large-scale genotyping identifies 41 new loci associated with breast cancer risk.Nat Genet，2013，45（4）：353-361.
13. Carthew RW，Sontheimer EJ.Origins and Mechanisms of miRNAs and siRNAs.Cell，2009，136（4）：642-655.
14. Mitchell PS，Parkin RK，Kroh EM，et al.Circulating microRNAs as stable blood-based markers for cancer detection.Proc Natl Acad Sci U S A，2008，105（30）：10513-10518.
15. Chen X，Ba Y，Ma L，et al.Characterization of microRNAs in serum：a novel class of biomarkers for diagnosis of cancer and other diseases.Cell Res，2008，18（10）：997-1006.
16. Chen X，Hu Z，Wang W，et al.Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.Int J Cancer，2012，130 （7）：1620-1628.
17. Zhu C，Ren C，Han J，et al.A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.Br J Cancer，2014，4.doi：10.1038/bjc.2014.119.
18. Alix-Panabières C，Schwarzenbach H，Pantel K.Circulating tumor cells and circulating tumor DNA.Annu Rev Med，2012，63：199-215.
19. Sastre J，Maestro ML，Puente J，et al.Circulating tumor cells in colorectal cancer：correlation with clinical and pathological variables.Ann Oncol，2008，19（5）：935-938.
20. Schwarzenbach H，Hoon DS，Pantel K.Cell-free nucleic acids as biomarkers in cancer patients.Nat Rev Cancer，2011，11（6）：426-437.
21. American Association for Cancer Research.AACR Cancer Progress Report 2013.Clin Cancer Res，2013，19 （Supplement 1）：S1-S86.
22. Centers for Disease Control and Prevention.Trends in current cigarette smoking among high school students and adults，United States，1965-2011.Available from：http：//www.cdc.gov/tobacco/data_statistics/tables/trends/cig _smoking/.
23. World Cancer Research Fund. Food，nutrition，physical activity，and the prevention of cancer：a global perspective.Washington，DC：American Institute for Cancer Research，2007.
24. Boyle T，Fritschi L，Heyworth J，et al. Long-term sedentary work and the risk of subsite-specific colorectal cancer.Am J Epidemiol，2011，173（10）：1183-1191.
25. Patel AV，Bernstein L，Deka A，et al.Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults.Am J Epidemiol，2010，172（4）：419-429.
26. Kushi LH，Doyle C，McCullough M，et al.American Cancer Society 2010 Nutrition and Physical Activity Guidelines Advisory Committee.American Cancer Society Guidelines on nutrition and physical activity for cancer prevention：reducing the risk of cancer with healthy food choices and physical activity.CA Cancer J Clin，2012，62 （1）：30-67.
27. Hans-JörgSenn，Ursula Kapp，Florian Otto.Cancer Prevention II.Springer-Verlag Berlin Heidelberg，2009.
28. McConnell JD，Roehrborn CG，Bautista OM，et al.The long-term effect of doxazosin，finasteride，and combination therapy on the clinical progression of benign prostatic hyperplasia.N Engl J Med，2003，349：2387-2398.
29. Andriole GL，Bostwick DG，Brawley OW，et al. REDUCE Study Group. Effect of dutasteride on the risk of prostate cancer.N Engl J Med，2010，362（13）：1192-1202.
30. Katki HA，Kinney WK，Fetterman B，et al.Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology：a population-based study in routine clinical practice.Lancet Oncol，2011，12（7）：663-672.
31. Herrero R，Quint W，Hildesheim A，et al.CVT Vaccine Group.Reduced prevalence of oral human papillomavirus （HPV）4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.PLoS One，2013，8 （7）：e68329.
32. Esserman L，Shieh Y，Thompson I.Rethinking screening for breast cancer and prostate cancer.JAMA，2009，302 （15）：1685-1692.
33. Weitzel JN，Blazer KR，Macdonald DJ，et al.Genetics，genomics，and cancer risk assessment：State of the Art and Future Directions in the Era of Personalized Medicine.CA Cancer J Clin，2011，19.doi：10.3322/caac.20128.
34.沈洪兵，靳光付.全基因组关联研究与复杂疾病风险预测的现状与展望.中华流行病学，2011，32：643-649.
35. Timothy R Rebbeck，Christine B Ambrosone，Peter G Shields.Molecular Epidemiology：Applications in Cancer and Other Human Diseases.Informa Healthcare，2008.
36. Chris Wild，Paolo Vineis，Seymour Garte.Molecular Epidemiology of Chronic Diseases.Wiley，2008.
上一章目录下一章